首页|细支气管肺泡癌80例临床治疗分析

细支气管肺泡癌80例临床治疗分析

Bronchiole tube Pulmonary Alveolus cancer 80 Example Clinical Treatment Analysis

扫码查看
目的:细支气管肺泡癌(BAC)是肺腺癌中的一个亚型。本研究探讨细支气管肺泡癌临床症状、病理类型、像特点、诊断治疗原则及预后。方法收集我院2000年1月至2006年1月收治的80例BAC患者的临床表现,探讨支气管管肺泡癌的治疗新模式及预后。结果综合治疗的疗效优于单一治疗效果。临床分期、病理类型、影像学特点、治疗原则与患者生存期密切相关。结论对BAC的治疗模式应以综合治疗为主。对晚期不能手术的患者应采用先化疗后分子靶向治疗的贯续疗法可取得较好的疗效。分析本组符合上述条件的27例病例,最长生存期为97个月,中位生存期为25个月。
Objective Bronchioloalveoar cell carcinoma(BAC)is in an adenocarcinoma of lung hypotype.This research is discussion bronchiole pulmonary alveolus cancer clinical symptom,pathology type,elephant characteristic,diagnosis treatment principle and prognosis.Method Collected from January,2000 80 example bronchiole tube bronchioloalveoar cell carcinoma(BAC)patient's clinical manifestation which admitted to January,2006,discussed the bronchial tube pulmonary alveolus cancer the treatment new pattern and the prognosis.Result Complex therapy curative effect surpasses the sole treatment result.Clinical by stages,pathology type,phantom study characteristic,treatment principle and patient lifetime close correlation.Conclusion The BAC treatment pattern should by the complex therapy primarily .Cannot the sur-gery patient be supposed to use first the chemotherapy after the later period the molecular target to continue the therapy to the treatment birthplace to be possible to obtain the good curative effect.Analyzes this group to conform to the above condition 27 example case of illness,the longest lifetime is 97 months,the position lifetime is 25 months.

Bronchioloalveoar cell carcinoma(BAC)PrognosisLifetime

王研、仇桂龙

展开 >

吉林省白山市通化矿业集团总医院,吉林 白山 134300

细支气管肺泡癌 治疗 预后 生存期

2014

中国保健营养(上旬刊)
全国卫生产业企业管理协会

中国保健营养(上旬刊)

ISSN:1004-7484
年,卷(期):2014.(4)
  • 1